2 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 2 | Terminated 2 |
Follow PharmaEngine: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer PEP503, Cisplatin, Radiotherapy - Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | Terminated | PharmaEngine | 12 | 2016-10-11 | 2022-01-11 |
| A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer PEP503, 5-fluorouracil, capecitabine - Rectal Cancer | Phase 1 / Phase 2 | Terminated | PharmaEngine | 32 | 2015-06-01 | 2022-01-11 |
Rectal Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Radiotherapy (2) · Capecitabine (1) · Cisplatin (1) · Fluorouracil (1)
Taiwan (2)
Cheng-Hsu Wang, M.D. (1) · Jwa-Yuan Wang, phD (1)